Number of NSQ drugs has declined considerably in Gujarat during the last 10 years: Dr H G Koshia: Shardul Nautiyal, Mumbai ...

AstraZeneca’s Calquence plus chemoimmunotherapy approved in EU to treat adult patients with previously untreated mantle cell lymphoma: Cambridge, UK Wednesday, May 7, 2025, 09:0 ...

Nandita Vijayasimha, Bengaluru Wednesday, May 7, 2025, 08:00 Hrs [IST] ...

Specialization in B Pharm will increase job opportunities for pharmacy graduates: Dr Deependra Singh: Peethaambaran Kunnathoor, Chennai Wednesday, May 7, 2025, 08:00 Hrs [IST] Dr ...

Indian healthcare sector notes rise of AI in operating theatres transforms surgical interventions: Nandita Vijayasimha, Bengaluru Wednesday, May 7, 2025, 08:00 Hrs [IST] Indian he ...

The DTAB has ratified the notification issued by the Centre in February, extending the timeline for implementation of the revised Schedule M manufacturing standards for manufacturers having turnover ...

Yashoda Medicity introduces Elekta Unity MR Linac with integrated CMM: Our Bureau, Mumbai Tuesday, May 6, 2025, 12:50 Hrs ...

Novavax announces significantly improved terms for collaboration and license pact with Takeda for Nuvaxovid in Japan: Gaithersburg, Maryland Tuesday, May 6, 2025, 14:00 Hrs [IST] ...

Neurocrine Biosciences announces new survey revealing need for routine screening and earlier diagnosis for people living with tardive dyskinesia: San Diego Tuesday, May 6, 2025, 1 ...

NRx Pharma files patent application for NRX-100, its proprietary, preservative free formulation of IV ketamine: Wilmington, Delaware Tuesday, May 6, 2025, 17:00 Hrs [IST] NRx Phar ...

Johnson & Johnson announces new data from Tremfya phase 3 QUASAR LTE study in adults with moderately-to-severely active ulcerative colitis: San Diego, California Tuesday, May 6, 2 ...

Vanda Pharma announces Bysanti NDA with US filing; US FDA decision expected in early 2026: Washington Tuesday, May 6, 2025, 18:00 Hrs [IST] Vanda Pharmaceuticals Inc. (Vanda) anno ...